Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer

NCT00003105 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter

Interventions

BIOLOGICAL: filgrastim
DRUG: cisplatin
DRUG: doxorubicin hydrochloride
DRUG: gemcitabine hydrochloride
DRUG: ifosfamide
DRUG: paclitaxel

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]